Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Receptor cholecystokinin

Cheng-Prasoff relationship, 65-66, 214 Cholecystokinin receptor antagonists, 80 Cimetidine, 9-10 Clark, Alfred J., 3, 3f, 12, 41 Clark plot, 114 Clearance, 165—166 Clinical pharmacokinetics, 165 Cocaine, 149, 150f Competitive antagonism description of, 114 Gaddum equation for, 101-102, 113,... [Pg.294]

Cheng, Z. J. and Miller, L. J. (2001) Agonist-dependent dissociation of oligomeric complexes of G protein-coupled cholecystokinin receptors demonstrated in living cells using bioluminescence resonance energy transfer. J. Biol. Chem. 276,48040-48047. [Pg.260]

Schmidt, W. E., and Schmitz, F. (2002) Cellular localization of cholecystokinin receptors as the molecular basis of the periperal regulation of acid secretion. Pharmacol. Toxicol. 91, 351-358. [Pg.180]

Gilbert, J.D., Hand, E.L., Yuan, A.S., Olah, TV. and Covey T.R. (1992) Determination of L-365,260, a new cholecystokinin receptor (CCK-B) antagonist, in plasma by liquid chromatography/atmospheric pressure chemical ionisation mass sectrometry Biological Mass Spectrometry, 21 (2), 63-68. [Pg.161]

Lesch KP, Wiesmann M, Hoh A (1992) 5-HTlA receptor-effector system responsivity in panic disorder. Psychopharmacology (Berl) 106 111-117 Levin AP, Doran AR, Liebowitz MR, Fyer AJ, Klein DF, Paul SM (1987) Pituitary adrenocortical unresponsiveness in lactate-induced panic. Psychiatry Res 21 23-32 Lines C, Challenor J, Traub M (1995) Cholecystokinin and anxiety in normal volunteers—an investigation of the anxiogenic properties of pentagastrin and reversal by the cholecystokinin receptor subtype-b-antagonist L-365,260. Br J Clin Pharmacol 39 235-242 Low K, Crestani F, Keist R, Benke D, Brunig I (2000) Molecular and neuronal substrate for the selective attenuation of anxiety. Science 290 131-134 Lucki I (1996) Serotonin receptor specificity in anxiety disorders. J Clin Psychiatry 57(Suppl 6) 5-10... [Pg.465]

Boden PR, Woodruff GN, Pinnock RD Pharmacology of a cholecystokinin receptor on 5-hydroxytryptamine neurons in dorsal raphe of the rat. Br J Pharmacol 102 635-638, 1991... [Pg.599]

Bradwejn J, Koszycki D CCK-4 and panic attacks in man, in Multiple Cholecystokinin Receptors in Man. Edited by Iversen S, Dourish C, Cooper F. Oxford, England, Oxford University Press, 1992, pp 121-131... [Pg.602]

Crawley JN Subtype-selective cholecystokinin receptor antagonists block cholecystokinin modulation of dopamine-mediated behaviors in the rat mesohmbic pathway. J Neurosci 12 3380-3391, 1992... [Pg.618]

Hill DR, Woodruff GN, Hughes J Cholecystokinin receptor subtypes and their potential involvement in anxiety, in Abstracts of Panels and Posters of the 32nd Annual Meeting of American College of Neuropsychopharmacology, Honolulu, HI, American College of Neuropsychopharmacology, 1993, p 58... [Pg.658]

Huang S, Fortune KP, Wank SA, et al Multiple affinity states of different cholecystokinin receptors. J Biol Chem 269 26121-26126, 1994 Hudson JL, Pope HG, Jonas JM, et al Phenomenologic relationship of eating disorders to major affective disorder. Psychiatry Res 9 345-354, 1983 Huey LY, Janowshy, DS, Judd LL, et al Effects of lithium carbonate on methylphenidate-induced mood, behavior, and cognitive processes. Psychopharmacology 73 161-164, 1981... [Pg.662]

Wang HY, Friedman E Chronic lithium desensitization of autoreceptors mediating serotonin release. Psychopharmacology 94 312-314, 1988 Wang HY, Friedman E Lithium inhibition of protein kinase C activation-induced serotonin release. Psychopharmacology 99 213-218, 1989 Wank SA, Pisegna JR, de Weerth A Brain and gastrointestinal cholecystokinin receptor family structure and functional expression. Proc Natl Acad Sci USA 89 8691-8695, 1992... [Pg.765]

Sundaram S, Dayan AD. Effects of a cholecystokinin receptor antagonist on rat exocrine pancreatic response to raw soya flour. Human Exp Toxicol 1991 10 179. [Pg.66]

This is indeed the case. In addition to gamma-aminobutyric acid (GABA), opiate and cholecystokinin receptor activities, the benzodiazepine scaffold is also found in muscle relaxants, antidepressants, neuroleptics, hypnotics, NK-1 receptor and vasopressin receptor antagonists, integrin antagonists, farnesyl transferase and phosphodiesterase inhibitors, potassium channel modulators, and others. [Pg.58]

Tachibana I Kanagawa K, Yamamoto Y, Otsuki M (1996) Pharmacological profile of a new serine derivative cholecystokinin receptor antagonist TP-680 on pancreatic, biliary and gastric function. J Pharmacol Exp Ther 279 1404-1412... [Pg.166]

Cooper SJ, Dourish CT, Barber DJ (1990b) Reversal of the anorectic effect of (+)-fenfluramine in the rat by the selective cholecystokinin receptor antagonist MK-329. Br J Pharmacol 99 65-70... [Pg.192]

Cholecystokinin receptors are the GPCRs CCK-A and CCK-B. The C-terminal sulfated octapeptide CCK fragment (CCK8) is a major neuropeptide. CCK is involved in anorexia, cardiovascular tonus, central respiratory control, nociception, pancreatic exocrine secretion, gastric emptying, memory, vigilance and emotional states such as anxiety and panic. [Pg.165]

Olvanil (= A-(Vanillyl)-9-oleamide] (vanilloid phenolic) Cholecystokinin receptor Synthetic (cf. Capsaicin) Anandamide transport inhibition [14] (VR agonist) 5.8D... [Pg.219]

CAT-REL, vesicular catecholamine release CB-R, cannabinoid receptor CB1-R, CB2-R, cannabinoid receptors CBD, chitin-binding domain CBG, cortisol-binding globulin CBZ-R, central benzodiazepine receptor CCK-R, cholecystokinin receptor CDC, chrysanthemum dicarboxylic acid CDK, cell division kinase, cyclin-dependent protein kinase... [Pg.840]

Gastrin and cholecystokinin receptor ligands consisting of lH-imidazole-4-yl-benzooxazole derivatives, (II), prepared by Kalindjian (3) were effective in controlling excess gastric acid secretion. [Pg.356]

The anxiety caused by pentagastrin is prevented by inhibiting cholecystokinin receptors (570). [Pg.690]

Lines C, Challenor J, Traub M. Cholecystokinin and anxiety in normal volunteers an investigation of the anxiogenic properties of pentagastrin and reversal by the cholecystokinin receptor subtype B antagonist L-365,260. Br J Clin Pharmacol 1995 39(3) 235-42. [Pg.715]

See other pages where Receptor cholecystokinin is mentioned: [Pg.228]    [Pg.237]    [Pg.172]    [Pg.294]    [Pg.257]    [Pg.419]    [Pg.274]    [Pg.460]    [Pg.142]    [Pg.248]    [Pg.522]    [Pg.603]    [Pg.654]    [Pg.657]    [Pg.657]    [Pg.702]    [Pg.720]    [Pg.760]    [Pg.762]    [Pg.591]    [Pg.72]    [Pg.58]    [Pg.55]    [Pg.378]    [Pg.209]    [Pg.219]   
See also in sourсe #XX -- [ Pg.419 ]

See also in sourсe #XX -- [ Pg.173 ]



SEARCH



Cholecystokinin

Cholecystokinin A receptor

Cholecystokinin B receptor

Cholecystokinin receptor ligands

Cholecystokinin-B receptor antagonists

© 2024 chempedia.info